Contract HHSO100201100034C

Elusys Therapeutics Inc · Department Of Health And Human Services · August 6, 2024

Cost Plus Fixed FeeFull & Open CompetitionNAICS 541711

Elusys Therapeutics Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on August 6, 2024 for an undisclosed amount of work in research and development in biotechnology. It was awarded under full and open competition. It uses cost-plus contract pricing. If all options are exercised, the contract could reach $69.59 million.

Potential value
$69.59M
if all options exercised
Modifications
0
Base award only

Contract details

PIID
HHSO100201100034C
Award type
Pricing
Cost Plus Fixed Fee
Set-aside
No Set Aside Used.
Competition
Full And Open Competition
NAICS
541711 · Research And Development In Biotechnology
Product / service
Research And Development Facilities
First action
August 6, 2024

Description

THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO DE-OBLIGATE CANCELING FUNDS FROM REQUISITION OS212728 OF $282,172.97, UPDATE SECTION F.2. DELIVERABLES, AND G.5. INVOICES/FINANCING REQUEST AND CONTRACT FINANCIAL REPORTING.

Modification timeline

  • August 6, 2024
    Mod P00024 · Other Administrative Action
    $62.15M

Similar contracts

RecipientAgencyDateObligated
University Of IllinoisDepartment Of Health And Human ServicesMarch 26, 2026$2.27M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 25, 2026$9.65M
University Of Texas Medical Branch At GalvestonDepartment Of Health And Human ServicesMarch 23, 2026$1.61M
Regeneron Pharmaceuticals IncDepartment Of Health And Human ServicesMarch 19, 2026$8.60M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 17, 2026$2.22M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 17, 2026$2.23M

Top contractors in NAICS 541711

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Alliance For Energy Innovation, Llc1$338.10M
2Battelle National Biodefense Institute, Llc2$24.13M
3Battelle Memorial Institute7$2.21M
4Bradshaw Engineering And Technical Services Llc1$0
5Uk Health Security Agency1$0
6Medicines Company, The1$0
7University Of North Carolina At Chapel Hill1$0
8Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center1$0
9Dnae Group Holdings Limited1$0
10University Of Texas Medical Branch At Galveston2$0

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract HHSO100201100034C?

Contract HHSO100201100034C is a federal contract awarded to Elusys Therapeutics Inc by Department Of Health And Human Services on August 6, 2024 for an undisclosed amount of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 0 times since the base award.

Who won contract HHSO100201100034C?

Elusys Therapeutics Inc won contract HHSO100201100034C from Department Of Health And Human Services.

How much is contract HHSO100201100034C worth?

Contract HHSO100201100034C has obligated $0 to date but carries a potential ceiling of $69.59 million if fully funded and all options are exercised.